GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NuVasive Inc (NAS:NUVA) » Definitions » Shiller PE Ratio

NuVasive (NuVasive) Shiller PE Ratio : 86.41 (As of May. 12, 2024)


View and export this data going back to 2004. Start your Free Trial

What is NuVasive Shiller PE Ratio?

As of today (2024-05-12), NuVasive's current share price is $39.75. NuVasive's E10 for the quarter that ended in Jun. 2023 was $0.46. NuVasive's Shiller PE Ratio for today is 86.41.

The historical rank and industry rank for NuVasive's Shiller PE Ratio or its related term are showing as below:

NUVA' s Shiller PE Ratio Range Over the Past 10 Years
Min: 136.69   Med: 168.84   Max: 276.83
Current: 136.69

During the past years, NuVasive's highest Shiller PE Ratio was 276.83. The lowest was 136.69. And the median was 168.84.

NUVA's Shiller PE Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 27.56 vs NUVA: 136.69

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

NuVasive's adjusted earnings per share data for the three months ended in Jun. 2023 was $0.140. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.46 for the trailing ten years ended in Jun. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


NuVasive Shiller PE Ratio Historical Data

The historical data trend for NuVasive's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuVasive Shiller PE Ratio Chart

NuVasive Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 201.88 233.03 148.52

NuVasive Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 153.88 170.15 148.52 147.43 136.69

Competitive Comparison of NuVasive's Shiller PE Ratio

For the Medical Devices subindustry, NuVasive's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NuVasive's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NuVasive's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where NuVasive's Shiller PE Ratio falls into.



NuVasive Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

NuVasive's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=39.75/0.46
=86.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NuVasive's E10 for the quarter that ended in Jun. 2023 is calculated as:

For example, NuVasive's adjusted earnings per share data for the three months ended in Jun. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=0.14/128.7287*128.7287
=0.140

Current CPI (Jun. 2023) = 128.7287.

NuVasive Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201309 0.160 98.790 0.208
201312 0.130 98.326 0.170
201403 -0.400 99.695 -0.516
201406 -0.090 100.560 -0.115
201409 -0.040 100.428 -0.051
201412 0.150 99.070 0.195
201503 0.610 99.621 0.788
201506 0.200 100.684 0.256
201509 0.240 100.392 0.308
201512 0.220 99.792 0.284
201603 -0.070 100.470 -0.090
201606 0.570 101.688 0.722
201609 0.070 101.861 0.088
201612 0.110 101.863 0.139
201703 0.220 102.862 0.275
201706 0.210 103.349 0.262
201709 0.640 104.136 0.791
201712 0.460 104.011 0.569
201803 -0.530 105.290 -0.648
201806 0.220 106.317 0.266
201809 0.300 106.507 0.363
201812 0.230 105.998 0.279
201903 0.180 107.251 0.216
201906 0.290 108.070 0.345
201909 0.210 108.329 0.250
201912 0.550 108.420 0.653
202003 0.100 108.902 0.118
202006 -0.980 108.767 -1.160
202009 0.110 109.815 0.129
202012 0.030 109.897 0.035
202103 -0.150 111.754 -0.173
202106 0.030 114.631 0.034
202109 -0.420 115.734 -0.467
202112 -0.710 117.630 -0.777
202203 0.350 121.301 0.371
202206 -0.020 125.017 -0.021
202209 -0.040 125.227 -0.041
202212 0.420 125.222 0.432
202303 -0.020 127.348 -0.020
202306 0.140 128.729 0.140

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


NuVasive  (NAS:NUVA) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


NuVasive Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of NuVasive's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NuVasive (NuVasive) Business Description

Traded in Other Exchanges
N/A
Address
12101 Airport Way, Broomfield, CO, USA, 92121
NuVasive Inc is a medical technology company focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, advance care and change lives. The company has a portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. It also develop and sell magnetically adjustable implant systems for spine and specialized orthopedic procedures.
Executives
Michael Farrington officer: SVP, People and Culture 7475 LUSK BLVD., SAN DIEGO CA 92121
Marc W. Rosenbaum officer: Chief Accounting Officer 7475 LUSK BLVD., SAN DIEGO CA 92121
James Christopher Barry director, officer: Chief Executive Officer 7475 LUSK BLVD, SAN DIEGO CA 92121
Andrew C. Morton officer: SVP, CHRO 10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Amy Belt Raimundo director ONE KAISER PLAZA, 22ND FLOOR, OAKLAND CA 94612
Lucas Vitale officer: Chief Human Resources Officer 7475 LUSK BLVD, SAN DIEGO CA 92121
Massimo Calafiore officer: EVP, Global Business Units 7475 LUSK BLVD., SAN DIEGO CA 92121
Siddhartha Kadia director 7475 LUSK BOULEVARD, SAN DIEGO CA 92121
Vickie L Capps director 2985 SCOTT STREET, VISTA CA 92083
Brent J. Boucher officer: EVP, Global Commercial 14 PLAZA DRIVE, LATHAM NY 12110
Matthew Link officer: Exec. VP U.S. Sales 7475 LUSK BLVD, SAN DIEGO CA 92121
Matthew K Harbaugh officer: EVP and CFO 675 MCDONNELL BLVD., HAZELWOOD MO 63042
Dale A. Wolf officer: SVP, Global Operations 7475 LUSK BLVD., SAN DIEGO CA 92121
Gregory T Lucier director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Paul Mcclintock officer: President, U.S. Commercial 7475 LUSK BLVD, SAN DIEGO CA 92121

NuVasive (NuVasive) Headlines

From GuruFocus